ARBUTUS BIOPHARMA CORP (ABUS) Stock Cash Flow
NASDAQ:ABUS - Nasdaq - CA03879J1003 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -69.92M | -72.85M | -69.46M | -76.25M | -63.75M | |||
| Depreciation Amortization | 1.38M | 1.40M | 1.43M | 1.75M | 1.98M | |||
| Income Taxes - Deferred | N/A | N/A | N/A | N/A | 0.00 | |||
| Change In Working Capital | -2.83M | -18.23M | 29.24M | 930.00K | 430.00K | |||
| Interest Paid | N/A | N/A | N/A | N/A | N/A | |||
| Other non cash items | 6.52M | 3.74M | 3.43M | 6.03M | 9.89M | |||
| OPERATING CASH FLOW | -64.85M | -85.94M | -35.36M | -67.53M | -51.44M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -182.00K | -1.01M | -510.00K | -810.00K | -230.00K | |||
| Other Investing Activity | 23.13M | 51.78M | -74.43M | -11.87M | -14.68M | |||
| INVESTING CASH FLOW | 22.95M | 50.77M | -74.94M | -12.68M | -14.91M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | N/A | |||
| Stock Issued/Repurchased | 52.00M | 30.65M | 31.81M | 137.24M | 86.75M | |||
| Other Financing Activity | N/A | N/A | N/A | N/A | 0.00 | |||
| FINANCING CASH FLOW | 52.00M | 30.65M | 31.81M | 137.24M | 86.75M | |||
| Exchange Rate Effect | -49.00K | 25.00K | -20.00K | 10.00K | 60.00K | |||
| CHANGE IN CASH | 10.04M | -4.49M | -78.51M | 57.04M | 20.46M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -64.85M | -85.94M | -35.36M | -67.53M | -51.44M | |||
| Capital Expenditure | -182.00K | -1.01M | -510.00K | -810.00K | -230.00K | |||
| FREE CASH FLOW | -65.03M | -86.94M | -35.87M | -68.34M | -51.67M | |||
All data in USD